The nation of Zimbabwe has turned down a significant US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years due to Washington's insistence on sensitive data.
This rejection became public after a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa believed the arrangement was "skewed".
A government spokesman later clarified that the US was seeking biological samples for research and profit while refused to guarantee the resulting advantages from any future medical innovations.
"We are forced to start the challenging and unfortunate process of winding down our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged continued negotiations to reach a agreement acceptable to both sides so the country's vital HIV programme can proceed.
Wider Implications
This development follows a comparable situation in neighbouring Kenya, where a court blocked a related health funding agreement following legal challenges were filed about the security of Kenyans' medical information.
After resuming the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had managed aid for the US government, but Trump stated its spending was "inefficient" and his administration was seeking government-to-government agreements to boost transparency and accountability.
As per statements, Sixteen African countries have so far agreed to similar health pacts, constituting more than $18.3bn in new funding.
Specifics of the Rejected Deal
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on HIV treatment via US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to surrender its biological resources and data for a long time, without any corresponding promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Put simply, our nation would provide the raw materials for medical research without any assurance that the end products would be available to our people if a future health crisis emerge."
National Interest and International Frameworks
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending structures previously established via the international organization.
Mangwana cited its Pandemic Benefit-Sharing framework designed to deal with potential global health emergencies.
"This system is intended to guarantee that when a nation provides its data, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," he added.
"We are open to further discussions with our US partners on how subsequent co-operation might be arranged in a way that honours the independence and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but suggested that negotiations need to persist given that much of the country's HIV programmes relied on external financing.
"If specific concerns arise, including those involving data governance or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," it commented.
The halted deal underscores the continuing challenges between accepting vital foreign assistance and safeguarding local interests in an ever more data-driven world.